Caris Life Sciences Inc
CAI22.000USD
+0.750+3.53%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
6.21BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Caris Life Sciences Inc Unternehmen
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Caris Life Sciences Inc Informationen
BörsenkürzelCAI
Name des UnternehmensCaris Life Sciences Inc
IPO-datumJun 18, 2025
CEOHalbert (David Dean)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeJun 18
Addresse750 W. John Carpenter Freeway
StadtIRVING
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl75039
Telefon18667718946
Websitehttps://www.carislifesciences.com/
BörsenkürzelCAI
IPO-datumJun 18, 2025
CEOHalbert (David Dean)
Führungskräfte von Caris Life Sciences Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
213.55M
98.49%
International
3.28M
1.51%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sat, Jan 31
Aktualisiert: Sat, Jan 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
Andere
33.40%
Aktionäre
Aktionäre
Anteil
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
Andere
33.40%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
48.48%
Investment Advisor
21.18%
Hedge Fund
11.06%
Private Equity
10.54%
Investment Advisor/Hedge Fund
5.08%
Pension Fund
0.53%
Research Firm
0.29%
Sovereign Wealth Fund
0.13%
Family Office
0.02%
Andere
2.70%
Institutionelle Beteiligung
Aktualisiert: Wed, Jan 21
Aktualisiert: Wed, Jan 21
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
228
134.49M
38.87%
--
2025Q4
258
136.99M
48.55%
+26.69M
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Halbert (David D)
122.76M
43.51%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.64%
--
--
Sep 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.18%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.68%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.59%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
9.58M
3.39%
+963.04K
+11.18%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
8.03M
2.84%
+721.77K
+9.88%
Sep 30, 2025
Braidwell LP
7.32M
2.59%
--
--
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.92M
2.45%
+154.50K
+2.29%
Sep 30, 2025
Silver Lake Partners
5.29M
1.88%
--
--
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
Mehr Anzeigen
ARK Genomic Revolution ETF
Anteil0.67%
Texas Capital Texas Small Cap Equity Index ETF
Anteil0.52%
Renaissance IPO ETF
Anteil0.43%
RiverNorth Patriot ETF
Anteil0.3%
Franklin Genomic Advancements ETF
Anteil0.29%
Invesco Russell 1000 Equal Weight ETF
Anteil0.08%
Inspire 500 ETF
Anteil0.07%
T Rowe Price Small-Mid Cap ETF
Anteil0.05%
Texas Capital Texas Equity Index ETF
Anteil0.04%
Fidelity Nasdaq Composite Index ETF
Anteil0.02%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
